InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Griggs Jonathan, Director. Director active across 1 company, notably Cumberland Pharmaceuticals INC. In total, 2 reports have been logged. History available since 17 March 2021. The latest transaction was disclosed on 17 March 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Jonathan Griggs is a Board Member at CUMBERLAND PHARMACEUTICALS INC. He has a strong background in corporate governance and strategic development. Jonathan contributes to guiding board decisions and implementing best practices within the company.